Discuss patent waiver extension for Covid diagnostics: Goyal urges G20

Commerce and Industry Minister Piyush Goyal on Thursday urged the G20 countries for starting timely discussions in the WTO on extending patent waiver for the production and supply of COVID-19 diagnostics and therapeutics. In June, members of the World Trade Organisation (WTO) agreed to grant a temporary patent waiver for manufacturing COVID-19 … Read more

Candor Technology secures patent for critical thinking product

He provided a comparison between his technology and prevailing methods: “Our repurchase exposures is now dramatically less than one basis point, or one-thousandth – probably more like one hundred thousandth – and the typical human process is 12 basis points.” That translates into a difference between $300 and $400 per loan by human methods versus … Read more

Pfizer, BioNTech seek to revoke CureVac’s patent infringement claims By Reuters

© Reuters. A vial labelled “CureVac COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration (Reuters) – Pfizer (NYSE:) and its German partner BioNTech have filed proceedings at the High Court of England and Wales, seeking a judgment that their COVID-19 vaccine, based on mRNA technology, does not infringe on CureVac’s … Read more

Pfizer, BioNTech seek to revoke CureVac’s patent infringement claims

(Reuters) — Pfizer and its German partner BioNTech have filed proceedings at the High Court of England and Wales, seeking a judgment that their COVID-19 vaccine, based on mRNA technology, does not infringe on CureVac’s European patents, according to a regulatory filing on Friday. In July, CureVac filed a patent lawsuit against BioNTech over its … Read more

Pricing regulator closely watching prices of diabetes drug going off patent

With more patients shifting to new gliptins (a category of diabetes drugs) as they go off-patent, the national pharma pricing regulator has moved quickly to cap prices of two diabetes molecules Sitagliptin and Linagliptin and their combinations. Around nine per cent of India’s 1.4 billion population has Type-2 diabetes, and this … Read more

Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine

(Reuters) – Moderna Inc. is suing Pfizer Inc. and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. Pfizer shares fell 1.4% before the bell while BioNTech was down about 2%. The lawsuit, which seeks undetermined … Read more

BioNTech, Pfizer sue CureVac over COVID vaccine patent claims

(Reuters) — COVID-19 vaccine maker BioNTech said Tuesday that it and partner Pfizer filed a complaint in U.S. District Court in Massachusetts, seeking a judgment that they did not infringe U.S. patents held by rival CureVac. The lawsuit, filed Monday, said CureVac is trying to profit from the success of BioNTech and Pfizer’s COVID-19 vaccines after CureVac’s … Read more

Comstock files for patent to produce renewable fuels from wood biomass (NYSE:LODE)

scanrail Comstock (NYSE:LODE) +8.9% post-market after saying Monday it filed for a new patent to produce renewable diesel, marine, sustainable aviation fuel and gasoline from wood biomass, “at dramatically improved yield, efficiency and cost in comparison to all known methods.” Comstock (LODE) said its plans to decarbonize with renewable fuels “involves abundant feedstocks that are … Read more